Marie‐Cécile Le Deley

11.5k total citations
177 papers, 5.0k citations indexed

About

Marie‐Cécile Le Deley is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Marie‐Cécile Le Deley has authored 177 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Pulmonary and Respiratory Medicine, 55 papers in Oncology and 37 papers in Pathology and Forensic Medicine. Recurrent topics in Marie‐Cécile Le Deley's work include Sarcoma Diagnosis and Treatment (48 papers), Lymphoma Diagnosis and Treatment (31 papers) and Glioma Diagnosis and Treatment (19 papers). Marie‐Cécile Le Deley is often cited by papers focused on Sarcoma Diagnosis and Treatment (48 papers), Lymphoma Diagnosis and Treatment (31 papers) and Glioma Diagnosis and Treatment (19 papers). Marie‐Cécile Le Deley collaborates with scholars based in France, United Kingdom and Germany. Marie‐Cécile Le Deley's co-authors include Laurence Brugières, Odile Oberlin, Didier Frappaz, Jacques Grill, Gilles Vassal, Jean Michon, Georges Delsol, Marie‐Anne Raquin, Hélène Pacquement and C Kalifa and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Brain.

In The Last Decade

Marie‐Cécile Le Deley

167 papers receiving 5.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marie‐Cécile Le Deley France 37 1.9k 1.4k 1.3k 1.3k 1.0k 177 5.0k
Christian Rübe Germany 38 3.4k 1.8× 614 0.4× 482 0.4× 1.4k 1.1× 1.3k 1.2× 150 7.0k
Normann Willich Germany 32 1.9k 1.0× 1.1k 0.8× 566 0.4× 931 0.7× 444 0.4× 203 4.1k
Ralph M. Meyer Canada 36 827 0.4× 1.8k 1.3× 550 0.4× 1.7k 1.3× 449 0.4× 139 4.7k
Ruth Ladenstein Austria 43 1.4k 0.7× 522 0.4× 3.3k 2.6× 1.3k 1.1× 1.7k 1.6× 204 5.5k
Julien Dômont France 35 2.5k 1.3× 677 0.5× 486 0.4× 2.0k 1.6× 594 0.6× 108 4.4k
Annalisa Trama Italy 30 1.9k 1.0× 543 0.4× 435 0.3× 2.3k 1.8× 605 0.6× 121 5.3k
David J. Straus United States 44 1.2k 0.6× 4.6k 3.3× 1.6k 1.3× 2.9k 2.3× 604 0.6× 175 6.5k
Dirk Hasenclever Germany 41 1.3k 0.7× 3.9k 2.8× 1.5k 1.2× 2.5k 2.0× 462 0.4× 128 5.9k
Douglas S. Hawkins United States 51 5.9k 3.0× 2.4k 1.7× 1.1k 0.8× 2.4k 1.9× 1.8k 1.7× 252 8.7k
Peter Mauch United States 54 2.1k 1.1× 5.1k 3.7× 1.8k 1.4× 3.7k 2.9× 1.0k 1.0× 242 10.8k

Countries citing papers authored by Marie‐Cécile Le Deley

Since Specialization
Citations

This map shows the geographic impact of Marie‐Cécile Le Deley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie‐Cécile Le Deley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie‐Cécile Le Deley more than expected).

Fields of papers citing papers by Marie‐Cécile Le Deley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie‐Cécile Le Deley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie‐Cécile Le Deley. The network helps show where Marie‐Cécile Le Deley may publish in the future.

Co-authorship network of co-authors of Marie‐Cécile Le Deley

This figure shows the co-authorship network connecting the top 25 collaborators of Marie‐Cécile Le Deley. A scholar is included among the top collaborators of Marie‐Cécile Le Deley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie‐Cécile Le Deley. Marie‐Cécile Le Deley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
André, Nicolás, Marie‐Cécile Le Deley, Isabelle Aerts, et al.. (2024). METRO-PD1: Phase 1 study of nivolumab in combination with metronomic chemotherapy in children and adolescents with relapsing/refractory solid tumors. European Journal of Cancer. 198. 113525–113525. 5 indexed citations
3.
Aladjidi, Nathalie, Audrey Contet, Jean‐Hugues Dalle, et al.. (2024). Outcome of childhood ALK‐positive anaplastic large cell lymphoma relapses: Real‐life experience of the French Society of Pediatric Oncology (SFCE) cohort of 75 French children. Pediatric Blood & Cancer. 72(1). e31397–e31397. 1 indexed citations
4.
Bogart, Emilie, Daniel Orbach, Marie‐Cécile Le Deley, et al.. (2024). Therapy and Outcomes of Patients with Relapsed Nonmetastatic Rhabdomyosarcoma: A Report from the French Society of Pediatric Oncology Malignant Mesenchymal Tumor Committee. Cancer Medicine. 13(23). e70420–e70420. 1 indexed citations
5.
Fournier, Clémence, Éric Leblanc, Marie‐Cécile Le Deley, et al.. (2023). Diagnostic Value of the Texture Analysis Parameters of Retroperitoneal Residual Masses on Computed Tomographic Scan after Chemotherapy in Non-Seminomatous Germ Cell Tumors. Cancers. 15(11). 2997–2997. 2 indexed citations
6.
Penel, Nicolas, Sylvie Bonvalot, Marie‐Cécile Le Deley, et al.. (2023). Pain in desmoid‐type fibromatosis: Prevalence, determinants and prognosis value. International Journal of Cancer. 153(2). 407–416. 8 indexed citations
7.
Adenis, Antoine, Guillaume Piessen, Samuel Le Sourd, et al.. (2023). Trimodality therapy with carboplatin/paclitaxel (CP) or FOLFOX (FFX) for esophageal/esogastric junctional cancer (EC/EGJ): Expanded safety and efficacy data from PROTECT.. Journal of Clinical Oncology. 41(4_suppl). 370–370.
8.
Penel, Nicolas, Sylvie Bonvalot, Alexandra Meurgey, et al.. (2022). Lack of Prognostic Value of CTNNB1 Mutation Profile in Desmoid-Type Fibromatosis. Clinical Cancer Research. 28(18). 4105–4111. 13 indexed citations
9.
Marec‐Bérard, Perrine, Valérie Laurence, Bob‐Valéry Occéan, et al.. (2019). Methotrexate–Etoposide–Ifosfamide Compared with Doxorubicin–Cisplatin–Ifosfamide Chemotherapy in Osteosarcoma Treatment, Patients Aged 18–25 Years. Journal of Adolescent and Young Adult Oncology. 9(2). 172–182. 12 indexed citations
10.
11.
Brodowicz, Thomas, Olivier Mir, Jennifer Wallet, et al.. (2018). Efficacy and safety of regorafenib compared to placebo and to post-cross-over regorafenib in advanced non-adipocytic soft tissue sarcoma. European Journal of Cancer. 99. 28–36. 15 indexed citations
12.
Foulon, Stéphanie, Bernadette Brennan, Nathalie Gaspar, et al.. (2016). Can postoperative radiotherapy be omitted in localised standard-risk Ewing sarcoma? An observational study of the Euro-E.W.I.N.G group. European Journal of Cancer. 61. 128–136. 55 indexed citations
13.
Lamora, Audrey, Julie Talbot, Gwenola Bougras, et al.. (2014). Overexpression of Smad7 Blocks Primary Tumor Growth and Lung Metastasis Development in Osteosarcoma. Clinical Cancer Research. 20(19). 5097–5112. 90 indexed citations
14.
15.
Monnet, Xavier, Martin Dres, Alexis Ferré, et al.. (2012). Prediction of fluid responsiveness by a continuous non-invasive assessment of arterial pressure in critically ill patients: comparison with four other dynamic indices. British Journal of Anaesthesia. 109(3). 330–338. 97 indexed citations
16.
Lamant, Laurence, Keith McCarthy, Emanuele S. G. d'Amore, et al.. (2011). Prognostic Impact of Morphologic and Phenotypic Features of Childhood ALK-Positive Anaplastic Large-Cell Lymphoma: Results of the ALCL99 Study. Journal of Clinical Oncology. 29(35). 4669–4676. 98 indexed citations
17.
Haddy, Nadia, Markhaba Tukenova, Catherine Guibout, et al.. (2011). Relationship between the brain radiation dose for the treatment of childhood cancer and the risk of long-term cerebrovascular mortality. Brain. 134(5). 1362–1372. 55 indexed citations
18.
Deley, Marie‐Cécile Le, Olivier Delattre, Karl‐Ludwig Schaefer, et al.. (2010). Impact of EWS-ETS Fusion Type on Disease Progression in Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor: Prospective Results From the Cooperative Euro-E.W.I.N.G. 99 Trial. Journal of Clinical Oncology. 28(12). 1982–1988. 125 indexed citations
19.
Ladenstein, Ruth, Ulrike Pötschger, Marie‐Cécile Le Deley, et al.. (2010). Primary Disseminated Multifocal Ewing Sarcoma: Results of the Euro-EWING 99 Trial. Journal of Clinical Oncology. 28(20). 3284–3291. 350 indexed citations
20.
Rubie, Hervé, Birgit Geoerger, Didier Frappaz, et al.. (2010). Phase I study of topotecan in combination with temozolomide (TOTEM) in relapsed or refractory paediatric solid tumours. European Journal of Cancer. 46(15). 2763–2770. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian Rübe Breakdown of academic impact, for papers by Normann Willich Breakdown of academic impact, for papers by Ralph M. Meyer Breakdown of academic impact, for papers by Ruth Ladenstein Breakdown of academic impact, for papers by Julien Dômont Breakdown of academic impact, for papers by Annalisa Trama Breakdown of academic impact, for papers by David J. Straus Breakdown of academic impact, for papers by Dirk Hasenclever Breakdown of academic impact, for papers by Douglas S. Hawkins Breakdown of academic impact, for papers by Peter Mauch
Rankless by CCL
2026